Literature DB >> 25525734

Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.

Michael J Holtzman1, Derek E Byers, Jennifer-Alexander Brett, Anand C Patel, Eugene Agapov, Xiaohua Jin, Kangyun Wu.   

Abstract

Respiratory infection is a common feature of the major human airway diseases, such as asthma and chronic obstructive pulmonary disease, but the precise link between acute infection and chronic lung disease is still undefined. In a mouse model of this process, parainfluenza virus infection is followed by long-term induction of IL-33 expression and release and in turn innate immune cell generation of IL-13 and consequent airway disease signified by excess mucus formation. IL-33 induction was traceable to a subset of secretoglobin-positive airway epithelial cells linked to progenitor/stem cell function. In corresponding studies of humans with chronic obstructive pulmonary disease, an increase in IL-33 production was also detected in concert with up-regulation of IL-13 and airway mucus formation. In this case, increased IL-33 production was localized to a subset of airway basal cells that maintain an endogenous capacity for increased pluripotency and ATP-regulated release of IL-33 even ex vivo. The results provide evidence of a sustainable epithelial cell population that may be activated by environmental danger signals to release IL-33 and thereby lead to IL-13-dependent disease. The progenitor nature of this IL-33-expressing ATP-responsive cell population could explain an acquired susceptibility to chronic airway disease. The findings may therefore provide a new paradigm to explain the role of viral infection and the innate immune system in chronic lung disease based on the influence of long-term epithelial progenitor cells programmed for excess IL-33 production. Further studies are needed to address the basis for this type of postviral reprogramming and the means to correct it and thereby restore airway mucosal immune function to normal.

Entities:  

Keywords:  IL-13; IL-33; airway epithelial cell; innate immune response; progenitor/stem cell

Mesh:

Substances:

Year:  2014        PMID: 25525734      PMCID: PMC4298973          DOI: 10.1513/AnnalsATS.201402-056AW

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  45 in total

Review 1.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

2.  The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses.

Authors:  Hideaki Kouzaki; Koji Iijima; Takao Kobayashi; Scott M O'Grady; Hirohito Kita
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

3.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

Authors:  Ya-Jen Chang; Hye Young Kim; Lee A Albacker; Nicole Baumgarth; Andrew N J McKenzie; Dirk E Smith; Rosemarie H Dekruyff; Dale T Umetsu
Journal:  Nat Immunol       Date:  2011-05-29       Impact factor: 25.606

4.  Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV(1) decline in a representative population sample.

Authors:  Roshan Brito-Mutunayagam; Sarah L Appleton; David H Wilson; Richard E Ruffin; Robert J Adams
Journal:  Chest       Date:  2010-04-23       Impact factor: 9.410

5.  The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium.

Authors:  Emma L Rawlins; Tadashi Okubo; Yan Xue; David M Brass; Richard L Auten; Hiroshi Hasegawa; Fan Wang; Brigid L M Hogan
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

6.  Macrophage chitinase 1 stratifies chronic obstructive lung disease.

Authors:  Eugene Agapov; John T Battaile; Rose Tidwell; Ramsey Hachem; G Alexander Patterson; Richard A Pierce; Jeffrey J Atkinson; Michael J Holtzman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-02       Impact factor: 6.914

Review 7.  Chronic obstructive pulmonary disease in non-smokers.

Authors:  Sundeep S Salvi; Peter J Barnes
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

8.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

Authors:  Edy Y Kim; John T Battaile; Anand C Patel; Yingjian You; Eugene Agapov; Mitchell H Grayson; Loralyn A Benoit; Derek E Byers; Yael Alevy; Jennifer Tucker; Suzanne Swanson; Rose Tidwell; Jeffrey W Tyner; Jeffrey D Morton; Mario Castro; Deepika Polineni; G Alexander Patterson; Reto A Schwendener; John D Allard; Gary Peltz; Michael J Holtzman
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

9.  Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.

Authors:  Min-Jong Kang; Chun Geun Lee; Jae-Young Lee; Charles S Dela Cruz; Zhijian J Chen; Richard Enelow; Jack A Elias
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.

Authors:  Patrick Mallia; Simon D Message; Vera Gielen; Marco Contoli; Katrina Gray; Tatiana Kebadze; Julia Aniscenko; Vasile Laza-Stanca; Michael R Edwards; Louise Slater; Alberto Papi; Luminita A Stanciu; Onn M Kon; Malcolm Johnson; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2010-10-01       Impact factor: 21.405

View more
  9 in total

Review 1.  Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

2.  The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation.

Authors:  Andrew Clerman; Zahid Noor; Rita Fishelevich; Virginia Lockatell; Brian S Hampton; Nirav G Shah; Mariah V Salcedo; Nevins W Todd; Sergei P Atamas; Irina G Luzina
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

3.  Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.

Authors:  Caroline M Percopo; Tyler A Rice; Todd A Brenner; Kimberly D Dyer; Janice L Luo; Kishore Kanakabandi; Daniel E Sturdevant; Stephen F Porcella; Joseph B Domachowske; Jesse D Keicher; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2015-07-02       Impact factor: 5.970

Review 4.  Interleukin 33 is a guardian of barriers and a local alarmin.

Authors:  Nikolas T Martin; Michael U Martin
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

5.  Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.

Authors:  Dinesh Devadoss; Arpan Acharya; Marko Manevski; Dominika Houserova; Michael D Cioffi; Kabita Pandey; Madhavan Nair; Prem Chapagain; Mehdi Mirsaeidi; Glen M Borchert; Siddappa N Byrareddy; Hitendra S Chand
Journal:  iScience       Date:  2022-06-30

6.  Escalating Mucus Inhibition to the Top of Our Priorities.

Authors:  Clemente J Britto; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2019-09       Impact factor: 6.914

7.  Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis.

Authors:  Wei Rao; Shan Wang; Marcin Duleba; Suchan Niroula; Kristina Goller; Jingzhong Xie; Rajasekaran Mahalingam; Rahul Neupane; Audrey-Ann Liew; Matthew Vincent; Kenichi Okuda; Wanda K O'Neal; Richard C Boucher; Burton F Dickey; Michael E Wechsler; Omar Ibrahim; John F Engelhardt; Tinne C J Mertens; Wei Wang; Soma S K Jyothula; Christopher P Crum; Harry Karmouty-Quintana; Kalpaj R Parekh; Mark L Metersky; Frank D McKeon; Wa Xian
Journal:  Cell       Date:  2020-04-15       Impact factor: 41.582

8.  Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.

Authors:  Kristi J Warren; Jill A Poole; Jenea M Sweeter; Jane M DeVasure; John D Dickinson; R Stokes Peebles; Todd A Wyatt
Journal:  Respir Res       Date:  2021-07-15

9.  Immune Modulation to Improve Survival of Viral Pneumonia in Mice.

Authors:  Shradha Wali; Jose R Flores; Ana M Jaramillo; David L Goldblatt; Jezreel Pantaleón García; Michael J Tuvim; Burton F Dickey; Scott E Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2020-12       Impact factor: 6.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.